Activating mutations in the MAP‐kinase pathway define non‐ossifying fibroma of bone-Reference-Cited by-同舟云学术

Activating mutations in the MAP‐kinase pathway define non‐ossifying fibroma of bone

Published:2019-01-24 Issue:1 Volume:248 Page:116-122
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Baumhoer Daniel¹,Kovac Michal¹,Sperveslage Jan²,Ameline Baptiste¹,Strobl Anna‐Christina³,Krause Arthur¹,Trautmann Marcel²⁴^ORCID,Wardelmann Eva²,Nathrath Michaela⁵⁶,Höller Sylvia¹,Hardes Jendrik⁷⁸,Gosheger Georg⁷,Krieg Andreas H⁹,Vieth Volker¹⁰,Tirabosco Roberto³,Amary Fernanda³,Flanagan Adrienne M³¹¹,Hartmann Wolfgang²⁴^ORCID

Affiliation:

1. Bone Tumour Reference Centre, Institute of PathologyUniversity Hospital Basel and University of Basel Basel Switzerland

2. Gerhard‐Domagk‐Institute of PathologyUniversity Hospital Münster Münster Germany

3. Histopathology DepartmentRoyal National Orthopaedic Hospital NHS Trust Stanmore UK

4. Division of Translational Pathology, Gerhard‐Domagk‐Institute of PathologyUniversity Hospital Münster Münster Germany

5. Department of Pediatric OncologyKlinikum Kassel Kassel Germany

6. Children's Cancer Research Centre and Department of Pediatrics, Klinikum rechts der IsarTechnische Universität München Munich Germany

7. Department of Orthopaedics and Tumour OrthopaedicsUniversity Hospital Münster Münster Germany

8. Department of Musculoskeletal Surgery, Sarcoma Centre EssenWestdeutsches Tumorzentrum Essen Germany

9. Paediatric Orthopaedic DepartmentUniversity Children's Hospital Basel Basel Switzerland

10. Department of RadiologyKlinikum Ibbenbüren Ibbenbüren Germany

11. Department of Pathology, UCL Cancer Institute London UK

Funder

Deutsche Forschungsgemeinschaft

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5216

Reference27 articles.

1. WHO Classification of Tumours of Soft Tissue and Bone 2013 IARC Press Lyon France GP Nielsen M Kyriakos C Fletcher J Bridge P Hogendoorn Non‐ossifying fibroma/benign fibrous histiocytoma of bone 302 304

2. Non‐ossifying fibroma in children: a surgical condition?;Mallet JF;Chir Pediatr,1980

3. Jaffe–Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder

4. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

5. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in molecular profiling of bone and soft tissue tumors;Skeletal Radiology;2024-01-17

2. Molecular pathogenesis of soft tissue and bone tumors;Diagnostic Molecular Pathology;2024

3. SYSTEMS BIOLOGY SIGNATURE FOR PROGNOSIS OF NON-OSSIFYING FIBROMA;Proceeding of the Shevchenko Scientific Society. Medical Sciences;2023-12-22

4. An unusually aggressive multiple non-ossifying fibroma of the distal tibia and fibula: A case report;Bone Reports;2023-12

5. Knochentumoren des Kindes- und Jugendalters;Die Pathologie;2023-10-12